‘I got regular mammograms, but my lobular breast cancer was invisible on the mammogram, even on the day before surgery. I have dense breast tissue and a family history of cancer. If only a gynaecologist had informed me that I needed occasional MRIs, I would have paid for them myself and spared myself the mastectomy, lymph node removal, and the complications that followed.’
‘I had two clear mammograms in 2012 and 2013, but in 2014, after a biopsy, I was diagnosed with Stage 3 lobular breast cancer. My cancer wasn’t detected through mammogram or ultrasound, only through an MRI. I later had a double mastectomy, chemotherapy, and radiation. Unfortunately, in 2022, my cancer metastasised to my omentum. My initial diagnosis was missed due to my dense breast tissue.’
Improved cancer screening programmes which include young women, accompanied by improved data collection and the application of cancer prevention strategies when they are most effective, are all essential to ensuring similar stories are not repeated anywhere in Europe again.
Join this special Roundtable to hear more about the effectiveness and limitations of breast imaging, treatment approaches, patient management and more as well as to share your insights with young cancer professionals.
Register now!
16:00-16:05 |
Welcome and introductions by Roundtable Co-Chairs |
|
|
16:05-16:20 |
Effectiveness and limitations of breast imaging in young patients and patients with dense breasts |
|
|
16:20-16:35 |
Pathophysiology of breast cancer in the context of dense breast |
|
|
16:35- 16:45 |
Open discussion and Q&A |
16:45-17:00 |
Treatment approach and patient management in the context of young breast cancer patients |
|
|
17:00-17:15 |
Patient representative to share their views |
|
|
17:15-17:25 |
Open discussion and Q&A |
17:25-17:30 |
Closing remarks by Co-Chairs |